N Ashwanikumar,1,* Nisha Asok Kumar,2,* S Asha Nair,2 GS Vinod Kumar11Chemical Biology, 2Cancer Research Programme, Rajiv Gandhi Center for Biotechnology, Poojappura, Thiruvananthapuram, Kerala, India *These authors contributed equally to this workAbstract: Methacrylic-based copolymers in drug-delivery systems demonstrate a pH-sensitive drug-releasing behavior in the colon. In this study, copolymers of methacrylic acid and 2-ethyl hexyl acrylate were prepared using a microemulsion polymerization technique. The purified copolymer was characterized by Fourier transform infrared spectroscopy, proton nuclear magnetic resonance spectroscopy, and differential scanning calorimetry. 5-Fluorouracil (5-FU) was entrapped within methacrylic-based copol...
Colorectal cancer is the fourth most common cancer worldwide and the third most frequently diagnosed...
A natural polysaccharide-based nanogel has been synthesized and characterized as pH-sensitive drug d...
textThe development of carriers to deliver a variety of cancer therapeutics orally would represent ...
The present study to deliver 5-Amino salicylic acid (5-ASA) for localized chemotherapy of inflammat...
Sima Singh,1,* Niranjan G Kotla,2,* Sonia Tomar,3 Balaji Maddiboyina,4 Thomas J Webster,5,6 Dinesh S...
Cancer is the second leading cause of death worldwide. To combat this disease, novel and specialized...
Abstract The use of 5-fluorouracil (5-FU) is associated with multifaceted challenges and poor pharma...
In the present investigation, new formulations of CMCS/AA hydrogels with varying composition of Carb...
A kind of novel fluorine-containing pH-responsive core/shell microgels poly(DMAEMA-co-HFMA)-g-PEG we...
Objective: The objective of this work is to prepare oral dosage systems based on enteric materials i...
Objective: The objective of this work was to obtain a water-soluble 5-fluorouracil (5-FU) polymeric ...
In this communication, we developed a thermally stable, biocompatible, and colonically degradable hy...
Chemotherapy constitutes a cornerstone in the treatment of cancer. Degradable polymeric nanogels are...
Parenteral administration of chemotherapeutic drugs, 5-fluorouracil (5-FU) and leucovorin (LV), is c...
Abstract5-Fluorouracil is used in the treatment of colorectal cancer along with oxaliplatin as first...
Colorectal cancer is the fourth most common cancer worldwide and the third most frequently diagnosed...
A natural polysaccharide-based nanogel has been synthesized and characterized as pH-sensitive drug d...
textThe development of carriers to deliver a variety of cancer therapeutics orally would represent ...
The present study to deliver 5-Amino salicylic acid (5-ASA) for localized chemotherapy of inflammat...
Sima Singh,1,* Niranjan G Kotla,2,* Sonia Tomar,3 Balaji Maddiboyina,4 Thomas J Webster,5,6 Dinesh S...
Cancer is the second leading cause of death worldwide. To combat this disease, novel and specialized...
Abstract The use of 5-fluorouracil (5-FU) is associated with multifaceted challenges and poor pharma...
In the present investigation, new formulations of CMCS/AA hydrogels with varying composition of Carb...
A kind of novel fluorine-containing pH-responsive core/shell microgels poly(DMAEMA-co-HFMA)-g-PEG we...
Objective: The objective of this work is to prepare oral dosage systems based on enteric materials i...
Objective: The objective of this work was to obtain a water-soluble 5-fluorouracil (5-FU) polymeric ...
In this communication, we developed a thermally stable, biocompatible, and colonically degradable hy...
Chemotherapy constitutes a cornerstone in the treatment of cancer. Degradable polymeric nanogels are...
Parenteral administration of chemotherapeutic drugs, 5-fluorouracil (5-FU) and leucovorin (LV), is c...
Abstract5-Fluorouracil is used in the treatment of colorectal cancer along with oxaliplatin as first...
Colorectal cancer is the fourth most common cancer worldwide and the third most frequently diagnosed...
A natural polysaccharide-based nanogel has been synthesized and characterized as pH-sensitive drug d...
textThe development of carriers to deliver a variety of cancer therapeutics orally would represent ...